9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Three New Cytotoxic ent-Kaurane Diterpenes from Isodon excisoides

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Three types of ent-kaurane diterpenoids were isolated from the aerial parts of Isodon excisoides, including three new diterpenoids, 1α,7α,14β-trihydroxy-20-acetoxy- ent-kaur-15-one ( 1); 1α,7α,14β,18-tetrahydroxy-20-acetoxy- ent-kaur-15-one ( 2); and 1α-acetoxy-14β-hydroxy-7α,20-epoxy- ent-kaur-16-en-15-one ( 3); together with six known diterpenes henryin ( 4); kamebanin ( 5); reniformin C ( 6); kamebacetal A ( 7); kamebacetal B ( 8); and oridonin ( 9). The structures of the isolated compounds were elucidated by means of nuclear magnetic resonance spectroscopy and high-resolution mass spectrometry in conjunction with published data for their analogs, as well as their fragmentation patterns. Compounds 5 and 9 were isolated from Isodon excisoides for the first time. To explore the structure-activity relationships of the isolated compounds, they were tested for their cytotoxic effects against five human cancer cell lines: HCT-116, HepG2, A2780, NCI-H1650, and BGC-823. Most of the isolated compounds showed certain cytotoxic activity against the five cancer cell lines with IC 50 values ranging from 1.09–8.53 µM. Among the tested compounds, compound 4 exhibited the strongest cytotoxic activity in the tested cell lines, with IC 50 values ranging from 1.31–2.07 µM. Compounds 1, 6, and 7 exhibited selective cytotoxic activity.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells

          Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, and is also highly resistant to conventional chemotherapy treatments. In this study, we report that Longikaurin A (LK-A), an ent-kaurane diterpenoid isolated from the plant Isodon ternifolius, induced cell cycle arrest and apoptosis in human HCC cell lines. LK-A also suppressed tumor growth in SMMC-7721 xenograft models, without inducing any notable major organ-related toxicity. LK-A treatment led to reduced expression of the proto-oncogene S phase kinase-associated protein 2 (Skp2) in SMMC-7721 cells. Lower Skp2 levels correlated with increased expression of p21 and p-cdc2 (Try15), and a corresponding decrease in protein levels of Cyclin B1 and cdc2. Overexpression of Skp2 significantly inhibited LK-A-induced cell cycle arrest in SMMC-7721 cells, suggesting that LK-A may target Skp2 to arrest cells at the G2/M phase. LK-A also induced reactive oxygen species (ROS) production and apoptosis in SMMC-7721 cells. LK-A induced phosphorylation of c-Jun N-terminal kinase (JNK), but not extracellular signal-regulated kinase and P38 MAP kinase. Treatment with, the JNK inhibitor SP600125 prevented LK-A-induced apoptosis in SMMC-7721 cells. Moreover, the antioxidant N-acetylcysteine prevented phosphorylation of both JNK and c-Jun. Taken together, these data indicate that LK-A induces cell cycle arrest and apoptosis in cancer cells by dampening Skp2 expression, and thereby activating the ROS/JNK/c-Jun signaling pathways. LK-A is therefore a potential lead compound for development of antitumor drugs targeting HCC.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Oridonin alters the expression profiles of MicroRNAs in BxPC-3 human pancreatic cancer cells

              Background Oridonin, an ingredient used in traditional Chinese medicine, has been demonstrated to play an important role in antitumour effects, but the mechanism underlying its antitumour properties is still not clear. Methods To verify the anti-cancer effects of oridonin via a miRNA-dependent mechanism, comprehensive miRNA expression profiling of oridonin-treated BxPC-3 human pancreatic cancer cells was performed using a miRNA microarray assay based on Sanger miR-Base Release 20, followed by a validation using real-time PCR. MicroRNA target prediction and Gene Ontology and KEGG pathway analysis were performed to investigate possible pathways involved. Results The results showed that 105 miRNAs were significantly differentially expressed (signal reading >500, p ≤ 0.01, |Log2-value| ≥1) in oridonin-treated BxPC-3 human pancreatic cancer cells. Conclusions Our data indicates that oridonin inhibits BxPC-3 cells probably through regulating the expression of miRNAs. Interruption of miRNA profiling may provide new therapeutic methods for the clinical treatment of pancreatic cancer.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                22 September 2015
                September 2015
                : 20
                : 9
                : 17544-17556
                Affiliations
                [1 ]School of pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China; E-Mails: zzdai@ 123456163.com (L.-P.D.); yqlu123@ 123456163.com (Y.-Q.L.)
                [2 ]Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; E-Mails: yujiaolong1977@ 123456aliyun.com (C.L.); huimin_gao@ 123456126.com (H.-M.G.)
                [3 ]Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Zhengzhou 450046, China
                [4 ]National Engineering Laboratory for Quality Control Technology of Chinese Herbal Medicine, Beijing 100700, China
                [5 ]Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100500, China; E-Mail: yanghanze@ 123456imm.ac.cn
                [6 ]Henan Province Hospital of TCM, Zhengzhou 450002, China; E-Mail: yuhongyan009@ 123456126.com
                Author notes
                [* ] Author to whom correspondence should be addressed; E-Mail: zhmw123@ 123456163.com ; Tel./Fax: +86-10-8401-4128.
                Article
                molecules-20-17544
                10.3390/molecules200917544
                6332174
                26402664
                e24aa809-c93a-4114-8d72-c209bab5b291
                © 2015 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 29 July 2015
                : 17 September 2015
                Categories
                Article

                isodon excisoides,ent-kaurane diterpene,cytotoxic activity,structure-activity relationship

                Comments

                Comment on this article